UOC
PROK icon

UBS O'Connor’s ProKidney PROK Stock Holding History

UBS O'Connor’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-49,782
Closed -$564K – 631
2023
Q1 		$564K Buy
+49,782
New +$530K 0.01% 458
2022
Q3 		– Sell
-362,372
Closed -$3.61M – 997
2022
Q2 		$3.61M Buy
+362,372
New +$3.58M 0.04% 426
2022
Q1 		– Sell
-257,885
Closed -$2.55M – 174
2021
Q4 		$2.55M Buy
257,885
+6,906
+3% +$68.3K 0.02% 459
2021
Q3 		$2.46M Buy
250,979
+200,979
+402% +$1.98M 0.02% 476
2021
Q2 		$506K Buy
+50,000
New +$506K ﹤0.01% 615

Other funds holding PROK

SCG
Social Capital Group Menlo Park, California $5.16M AUM 66.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS O'Connor's PROK Position: Q2 2023 in Review

UBS O'Connor sold out of ProKidney (PROK) in Q2 2023, closing a stake of 49,782 shares — an estimated $564K sold.

UBS O'Connor first reported a position in PROK in Q2 2021 and held it in 5 quarters. The position peaked at $3.61M in Q2 2022. 56 funds tracked by Wall St. Rank hold PROK as of Q2 2023.

  • UBS O'Connor reported no remaining ProKidney position as of Q2 2023 after selling out during the quarter.
  • UBS O'Connor sold 49,782 ProKidney shares in Q2 2023, an estimated $564K.
  • UBS O'Connor first reported a position in ProKidney in Q2 2021 and held it in 5 quarters.
  • UBS O'Connor's ProKidney position peaked at $3.61M in Q2 2022.
  • 56 funds tracked by Wall St. Rank held ProKidney as of Q2 2023.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.